Skip to main content Scroll Top
19th Ave New York, NY 95822, USA

Participation in ROHEALTH 2026

Doctor reveals errors in the treatment of the large intestine .

ROHEALTH is a Romanian health and bioeconomy cluster that brings together a diverse network of stakeholders, including companies from the medical, pharmaceutical and biotechnology sectors, digital health developers, research institutes, universities, hospitals, and other organizations active in healthcare innovation. The cluster supports collaboration between its members by facilitating partnerships, encouraging joint project development, promoting access to national and European funding opportunities, and contributing to dialogue on public policies relevant to health and bioeconomy. Through these activities, ROHEALTH aims to strengthen cooperation across the sector and support the development and implementation of innovative solutions in healthcare.

The ROHEALTH Annual General Assembly 2026 took place on January 28–29, bringing together members of ROHEALTH for two days of in person discussions and working sessions. The event offered a structured setting for dialogue and coordination among organizations active in health and bioeconomy.

The first day focused on aligning priorities and ongoing activities within the cluster, while the second day had a more practical orientation. During the event, discussions were focused on funding opportunities, collaboration frameworks, and public policy consultation, highlighting the role of cooperation and financing in supporting innovation. These exchanges reflected the need for clear coordination between research, industry, and healthcare stakeholders.

For projects such as ONCOSCREEN, participation in this event important because it connects our research and innovation efforts to a wider ecosystem. Topics covered included prevention, early detection, and digital healthcare, mirroring broader challenges faced by healthcare systems today and emphasizing the need for solutions that are both effective and applicable in a range of contexts.

Beyond the formal agenda, the assembly offered a space for direct interaction between members of the cluster. These face to face exchanges and informal discussions play a key role in identifying future collaboration opportunities.

In conclusion, ROHEALTH AGA 2026 provided a valuable opportunity for ONCOSCREEN to stay connected to the cancer screening community, exchange perspectives, and reinforce collaboration across the health and bioeconomy ecosystem. Participation in such events supports a shared understanding of priorities and helps ensure that innovation remains closely linked to real needs and collective goals.